These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 6467499)
21. Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide, 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea, and L-phenylalanine mustard on B16, Cloudman S91, and Harding-Passey mouse melanomas. Hill HZ; Hill GJ; Miller CL; Pfaller M; Weiss K; Galin M Cancer Res; 1979 Mar; 39(3):934-9. PubMed ID: 427782 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and antitumor activity of halogen-substituted 4-(3,3-dimethyl-1-triazeno)quinolines. Lin AJ; Loo TL J Med Chem; 1978 Mar; 21(3):268-72. PubMed ID: 628002 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and antileukemic activities of furanyl, pyranyl, and ribosyl derivatives of 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide and 3-(3,3-dimethyl-1-triazeno)pyrazole-4-carboxamide. Earl RA; Townsend LB J Med Chem; 1979 Nov; 22(11):1422-5. PubMed ID: 533891 [TBL] [Abstract][Full Text] [Related]
24. Tumor inhibitory triazenes. 2. Variation of antitumor activity within an homologous series. Wilman DE; Goddard PM J Med Chem; 1980 Sep; 23(9):1052-4. PubMed ID: 7411549 [TBL] [Abstract][Full Text] [Related]
25. Chemotherapy and immunotherapy of L1210 leukemic mice with antigenic tumor sublines. Nicolin A; Canti G; Marelli O; Veronese F; Goldin A Cancer Res; 1981 Apr; 41(4):1358-62. PubMed ID: 7011535 [TBL] [Abstract][Full Text] [Related]
26. Experimental studies at Southern Research Institute with DTIC (NSC-45388). Montgomery JA Cancer Treat Rep; 1976 Feb; 60(2):125-34. PubMed ID: 1260770 [TBL] [Abstract][Full Text] [Related]
27. Treatment of grade III and IV astrocytoma with dimethyl triazeno imidazole carboxamide (DTIC, NSC-45388) alone and in combination with CCNU (NSC-79037) or methyl CCNU (MeCCNU, NSC-95441). Taylor SG; Nelson L; Baxter D; Rosenbaum C; Sponzo RW; Cunningham TJ; Olson KB; Horton J Cancer; 1975 Oct; 36(4):1269-76. PubMed ID: 169984 [TBL] [Abstract][Full Text] [Related]
28. Letter: Disseminated intravascular coagulation syndrome with metastatic melanoma: Remission after treatment with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC). Susens GP; Hendrickson C; Barto DA; Sams BJ Ann Intern Med; 1976 Feb; 84(2):175-6. PubMed ID: 1252046 [No Abstract] [Full Text] [Related]
29. Comparative studies on the chemical stability and therapeutic effectiveness of water-insoluble 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) and its water-soluble hydrochloride against L1210 mouse leukemia. Woodman RJ; Kline I; Field RB; Gang M Cancer Chemother Rep; 1973; 57(4):383-91. PubMed ID: 4762437 [No Abstract] [Full Text] [Related]
30. Reproduction and teratology studies with oncolytic agents in the rat and rabbit. II. 5-(3,3-dimethyl-l-triazeno)imidazole-4-carboxamide (DTIC). Thompson DJ; Molello JA; Strebing RJ; Dyke IL Toxicol Appl Pharmacol; 1975 Aug; 33(2):281-90. PubMed ID: 1179433 [No Abstract] [Full Text] [Related]
31. Effect of scheduling of combinations of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on the Harding-Passey and Cloudman S91 mouse melanomas. Hill HZ; Hill GJ Cancer Res; 1982 Mar; 42(3):838-42. PubMed ID: 7059982 [TBL] [Abstract][Full Text] [Related]
32. Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide and its metabolites on Novikoff hepatoma cells. Beal DD; Skibba JL; Whitnable KK; Bryan GT Cancer Res; 1976 Aug; 36(8):2827-31. PubMed ID: 179708 [TBL] [Abstract][Full Text] [Related]
33. 5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma. Carter SK; Friedman MA Eur J Cancer (1965); 1972 Feb; 8(1):85-92. PubMed ID: 4552317 [No Abstract] [Full Text] [Related]
34. Effect of cobalt-60 gamma rays and DTIC (5-(3,3 dimethyl-1-triazeno)-imidazole-r-carboxamide) on human malignant melanomas grown in athymic nude mice. Rofstad EK; Brustad T; Johannessen JV; Mossige J Br J Radiol; 1977 May; 50(593):314-20. PubMed ID: 861450 [TBL] [Abstract][Full Text] [Related]
35. [Dimethyl-triazeno-imidazol-carboxamide (DTIC)--a new cytostatic agent]. Klepp O Tidsskr Nor Laegeforen; 1975 Sep; 95(27):1550-1. PubMed ID: 1179374 [No Abstract] [Full Text] [Related]
36. Long-term depression of two primary immune responses induced by a single dose of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC). Puccetti P; Giampietri A; Fioretti MC Experientia; 1978 Jun; 34(6):799-800. PubMed ID: 658308 [TBL] [Abstract][Full Text] [Related]
37. Selective toxicity of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide toward hypoxic mammalian cells. Rauth AM; Mohindra JK Cancer Res; 1981 Dec; 41(12 Pt 1):4900-5. PubMed ID: 7198008 [TBL] [Abstract][Full Text] [Related]
38. In vitro generation of a highly immunogenic subline of L1210 leukemia following exposure to 5-(3,3'-dimethyl-1-triazeno)imidazole-4-carboxamide. Contessa AR; Bonmassar A; Giampietri A; Circolo A; Goldin A; Fioretti MC Cancer Res; 1981 Jun; 41(6):2476-82. PubMed ID: 7016315 [TBL] [Abstract][Full Text] [Related]
39. Adoptive immunity in mice challenged with L1210/DTIC clones. Canti G; Ricci L; Marelli O; Franco P; Nicolin A Cancer Immunol Immunother; 1987; 24(1):64-7. PubMed ID: 3545466 [TBL] [Abstract][Full Text] [Related]
40. Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma. Costanza ME; Nathanson L; Costello WG; Wolter J; Brunk SF; Colsky J; Hall T; Oberfield RA; Regelson W Cancer; 1976 Apr; 37(4):1654-9. PubMed ID: 769936 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]